AQP4 and neuromyelitis optica: This corroborates findings from previous, smaller studies, which found that AQP4-Ab seropositivity in patients with isolated ON or myelitis confers a high risk of conversion to NMO within one year [18-21] and strongly underlines the need for early prophylactic treatment in patients presenting with seropositive isolated ON or myelitis.